Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.

Suppr

超能文献

作者信息

Viallet J, Ihde D C

机构信息

National Cancer Institute Bethesda, MD.

出版信息

J Clin Oncol. 1989 Aug;7(8):985-7. doi: 10.1200/JCO.1989.7.8.985.

DOI:10.1200/JCO.1989.7.8.985

PMID:2547029

Abstract

摘要

相似文献

Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.

J Clin Oncol. 1989 Aug;7(8):985-7. doi: 10.1200/JCO.1989.7.8.985.

A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.

J Clin Oncol. 1989 Aug;7(8):993-1002. doi: 10.1200/JCO.1989.7.8.993.

Current chemotherapy of small cell lung cancer.

Chest. 1986 Apr;89(4 Suppl):258S-263S. doi: 10.1378/chest.89.4_supplement.258s.

Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.

Am J Clin Oncol. 1984 Oct;7(5):419-23. doi: 10.1097/00000421-198410000-00006.

A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.

J Clin Oncol. 1988 Jan;6(1):5-8. doi: 10.1200/JCO.1988.6.1.5.

A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification.

Am J Clin Oncol. 1994 Dec;17(6):527-37. doi: 10.1097/00000421-199412000-00016.

Non small cell lung cancer and chemotherapy.

Monaldi Arch Chest Dis. 1994 Apr;49(2):177-8.

Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy.

Tumori. 1991 Dec 31;77(6):506-10.

[Multidisciplinary treatment for small cell lung cancer].

Gan To Kagaku Ryoho. 1984 Mar;11(3):474-9.

[Pilot study of multi-cyclic combination chemotherapy in small cell lung cancer].

Gan To Kagaku Ryoho. 1991 Mar;18(3):489-92.

引用本文的文献

Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.

Mol Cell Biol. 2001 Dec;21(24):8385-97. doi: 10.1128/MCB.21.24.8385-8397.2001.

Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line.

Cancer Chemother Pharmacol. 1994;34(3):242-8. doi: 10.1007/BF00685084.

Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant.

Cancer Immunol Immunother. 1991;33(4):274-7. doi: 10.1007/BF01744948.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验